Hana Biosciences
About Us
Investor Relations
Press Releases
Events & Webcasts
Presentations & Publications
Corporate Governance
Financial Information
Stock Information
Contact Us
Shareholder Tools
Briefcase Shareholder Briefcase
Printed Materials Printed Materials
Email Alerts Email Alerts
Download Center Download Library
RSS RSS News Feeds
Search Investor Relations


Investor Relations

Hana Biosciences, Inc. is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to strengthen the foundation of cancer care. The company is committed to creating value by building a best in-class team, accelerating the development of lead product candidates, expanding its pipeline by being the alliance partner of choice, and nurturing a unique company culture.

OTCBB: HNAB.OB
Last Price $0.16  
Change - 0.01 3.03%
Volume 53,800
Last Trade Jul 29, 2010
3:00 PM ET
Quotes delayed at least 20 minutes. Information provided by eSignal.

Recent Releases

Jul 8, 2010
Hana Biosciences Patent Issued for Menadione for the Prevention and Treatment of EGFR Inhibitor Cancer Therapy-Associated Rash

Jun 7, 2010
Hana Biosciences Announces Financing of Up to $100 Million

View all releases »